Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06526247 · ClinicalTrials.gov registry record · NA

Evaluating Interventions for Intimate Partner Violence Use in Washington State

A NA study of Intimate Partner Violence, sponsored by Boston University.

Recruiting
Registry status
NA
Development phase
800
Enrollment target
1
Study location

NCT06526247: Recruiting NA study of Intimate Partner Violence, sponsored by Boston University.

NCT06526247 is a NA study of Intimate Partner Violence that is actively recruiting participants, run by Boston University. The registered enrollment target is 800 participants, above the 300-participant average among 14 other Intimate Partner Violence trials with a reported enrollment target (167% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06526247, a NA study of Intimate Partner Violence, is actively recruiting participants, sponsored by Boston University.

RECRUITING
Registry status
NA
Development phase
800 participants
Enrollment target
1
Study location

Study Summary

Intimate partner violence (IPV), specifically physical and psychological aggression toward an intimate partner, represents a public health crisis that affects millions of Americans each year. There currently exists very little evidence from randomized controlled trials for the effectiveness of abuser intervention programs designed to prevent and end perpetration of IPV in the general population. This is troubling considering that approximately half a million men and women are court-mandated to these programs each year. The investigators will conduct a randomized control trial (RCT) investigating the efficacy of the Strength at Home (SAH) intervention in reducing intimate partner violence (IPV). The overarching aim of this study is to test the efficacy of SAH with court-involved-partner-violent men through an RCT comparing those who receive SAH with those who receive other standard IPV interventions offered in the state of Washington (treatment as usual- TAU). The specific aims are: 1.1: Compare the frequency of physical and psychological IPV, the primary outcomes of interest, across conditions as reported by the male participants and their intimate partners across Time 1 (baseline) and four 3-month follow ups (Times 2-5). It is expected that greater reductions in IPV frequencies will be evidenced in SAH than TAU over the course of the year. 1.2: Compare symptoms of PTSD, alexithymia, and alcohol use problems across conditions and assessment time points as reported by the male participants. It is expected that greater reductions in these symptoms will be evidenced in SAH than TAU over the course of the year. 1.3: Compare treatment satisfaction across conditions as reported by the male participants across the four 3-month follow ups (Times 2-5). It is expected that treatment satisfaction will be higher in SAH than TAU.

Primary Outcome

The revised Conflict Tactics Scales (CTS2), a 20-item instrument, will be used to assess IPV. The Physical Assault (12 items) and Psychological Aggression (8 items) subscales will be administered. Each of the 20 items is scored by the frequency of occurrence of the item with 8 choices 1-7 and 0.

Conditions Studied

Interventions

  • BEHAVIORAL Strength at Home (SAH)
  • BEHAVIORAL Treatment as usual for IPV

Study Locations (1)

Massachusetts

  • BU Chobanian & Avedisian School of Medicine, Psychiatry - Boston

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2024-11-18
Est. Completion 2027-07
Phase NA
Boston University

185 total trials

What NCT06526247 shows while recruiting

NCT06526247 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, above the 300-participant average among 14 other Intimate Partner Violence trials with a reported enrollment target (167% higher).

The record links to 1 condition, with Intimate Partner Violence appearing as the primary indexed condition, and to 2 interventions - of which Strength at Home (SAH) is the first listed.

NCT06526247 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06526247 about?

NCT06526247 is a clinical study titled "Evaluating Interventions for Intimate Partner Violence Use in Washington State". Intimate partner violence (IPV), specifically physical and psychological aggression toward an intimate partner, represents a public health crisis that affects millions of Americans each year. There currently exists very little evidence from randomized controlled trials for the effectiveness of abuse...

What is the current status of trial NCT06526247?

This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2024-11-18. Estimated completion is 2027-07.

What conditions does trial NCT06526247 study?

This clinical trial studies the following conditions: Intimate Partner Violence.

What interventions are being tested in trial NCT06526247?

The interventions under investigation include: Strength at Home (SAH) (BEHAVIORAL), Treatment as usual for IPV (BEHAVIORAL).

Who is sponsoring clinical trial NCT06526247?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06526247 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intimate Partner Violence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06526247's enrollment target sits among peer trials

800 2nd of 14 the highest of 14 other Intimate Partner Violence trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Intimate Partner Violence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00695214 · 800 participants · Phase 2

    Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea

  • NCT03048201 · 800 participants · NA

    Physica System Total Knee Replacement Registry Study

  • NCT03792659 · 800 participants

    The EXPLORE MG Registry for Myasthenia Gravis

  • NCT03819296 · 800 participants · Phase 1

    Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06526247, the US trial registry maintained by the National Library of Medicine. NCT06526247 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.